Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 VACCINE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05682625
What this trial is testing

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Stanford University
Not applicableStudy completedNCT04834726
What this trial is testing

COVID-19 Vaccine Text Outreach

Who this might be right for
Covid19
University of Pennsylvania 19,554
Post-approval studies (Phase 4)Study completedNCT04992208
What this trial is testing

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 31,041
Testing effectiveness (Phase 2)UnknownNCT05043285
What this trial is testing

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT05046548
What this trial is testing

This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19

Who this might be right for
Coronavirus InfectionsVaccine
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products 400
Not applicableUnknownNCT04910971
What this trial is testing

Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year

Who this might be right for
COVID-19 VaccineCorona Virus InfectionVaccine Adverse Reaction+3 more
LifeBridge Health 60
Post-approval studies (Phase 4)Study completedNCT05079633
What this trial is testing

A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adults

Who this might be right for
Covid19 Vaccine
National Taiwan University Hospital 220
Not applicableUnknownNCT05831826
What this trial is testing

Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China

Who this might be right for
COVID-19 VaccinesAutoimmune Diseases
Zhejiang Chinese Medical University 1,200
Large-scale testing (Phase 3)UnknownNCT05163652
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

Who this might be right for
SARS-CoV-2 Infection
Chinese Academy of Medical Sciences 432
Not applicableStudy completedNCT04843917
What this trial is testing

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

Who this might be right for
Coronavirus 2019Healthcare WorkersVaccine
Hospital Italiano de Buenos Aires 100
Large-scale testing (Phase 3)Study completedNCT05398848
What this trial is testing

Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)

Who this might be right for
COVID-19
Jiangsu Rec-Biotechnology Co., Ltd. 7,623
Early research (Phase 1)Study completedNCT04760743
What this trial is testing

Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)

Who this might be right for
COVID-19 (Healthy Volunteers)
SK Bioscience Co., Ltd. 50
Not applicableStudy completedNCT04974164
What this trial is testing

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 1,400
Early research (Phase 1)Study completedNCT04495933
What this trial is testing

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Who this might be right for
SARS-CoV2Covid19
The University of Queensland 216
Testing effectiveness (Phase 2)UnknownNCT05033847
What this trial is testing

Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

Who this might be right for
COVID-19 PneumoniaCoronavirus Infections
National Vaccine and Serum Institute, China 1,800
Early research (Phase 1)UnknownNCT05364047
What this trial is testing

Clinical Trial of SARS-CoV-2 mRNA Vaccine in China

Who this might be right for
COVID-19
AIM Vaccine Co., Ltd. 144
Testing effectiveness (Phase 2)UnknownNCT05409261
What this trial is testing

Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine

Who this might be right for
COVID-19Vaccine ReactionSARS CoV 2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Large-scale testing (Phase 3)UnknownNCT05164731
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

Who this might be right for
SARS-CoV2 Infection
Chinese Academy of Medical Sciences 880
Testing effectiveness (Phase 2)Study completedNCT05069623
What this trial is testing

Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers

Who this might be right for
COVID-19Infection ViralInfections
Nykode Therapeutics ASA 68
Early research (Phase 1)Study completedNCT04313127
What this trial is testing

Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults

Who this might be right for
COVID-19
CanSino Biologics Inc. 108
Next Page